[Synergistic effects of paclitaxel and gemcitabine on androgen-independent prostate cancer].
Sun
Ming
M
Department of Urology, West China Hospital, Sichuan University, Chengdu 610041, China. sunming2003@163.com
Yang
Yu-ru
YR
Li
Hong
H
Chen
Yi-rong
YR
Wang
Zhi-ping
ZP
Lu
Yi-ping
YP
Wei
Qiang
Q
Yue
Zhong-jin
ZJ
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D045744:Cell Line, Tumor; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000494:pharmacology; D004357:Drug Synergism; D006801:Humans; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D017239:Paclitaxel / Q000494:pharmacology*; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000473:pathology*; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D003841:Deoxycytidine; D017430:Prostate-Specific Antigen; D017239:Paclitaxel; D000093542:Gemcitabine